Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Life Science Startup Investors in Singapore in November 2024

Last updated: Nov 2024 A list of 15 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Singapore. We rank investors based on the number of investments they made in Life science companies from Singapore. We update this investor list every month.

Top 15 Life Science Startup Investors in Singapore in November 2024

Investor	Life Science Singapore investments
Anzu Partners	3
UTEC - The University of Tokyo Edge Capital Partners	3
EDBI	3
Eisai	2
Nestlé	1
Temasek Holdings	1
Hana Financial Investment	1
K3 Ventures	1
Lightstone Ventures	1
Seeds Capital	1
SK Securities	1
Partners Investment	1
KB Financial Group	1
Altara Ventures	1
Amgen Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Software, Manufacturing
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
CytoTronics — CytoTronics allows you to visualize live cell function in real time and at scale using a revolutionary approach to studying cell biology, powered by microchips.

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
Japan, United States, Singapore

Portfolio highlights

Estie — Estie is a Development of AI / machine learning algorithm and new business in real estate company.
Liminal — Advanced battery inspection and metrology with ultrasound and machine learning
SUN METALON — Next Generation Sustainable Metal Manufacturing

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, China

Portfolio highlights

Zinc Money — A suite of comprehensive solutions to help families navigate international education for their children and ensure a sound financial foundation for their academic journey.
Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
Arta Finance — Arta is a digital wealth platform offering unifying your investments, financial planning, tax and estate planning in one. Access elite private investment fund managers, along with intelligent investment tools for public markets.

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

Nestlé manufactures and sells food and beverage for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestlé, Nescafé, Perrier, Pure Life, and Purina. Nestlé also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Investment focus

Food and Beverage, Health Care, Therapeutics
Private Equity, Grant, Funding Round
United States, United Kingdom, Egypt

Portfolio highlights

GuateValley — GuateValley interconnects local guides with travelers to live experiences in little-known destinations.
Sundial Foods — Sundial Foods utilizes a macro and microstructural engineering approach to create plant-based meat alternatives for conscious consumers.The company is passionate about making the affordable, accessible, and nutritional value of plant-based meats, made from ingredients that customers know and created using simple processes.It is headquartered inBerkeley, California in 2019.
Origin Materials — Origin is a new kind of chemical company, focused on the future of materials science.

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 900 people. Our portfolio is valued at S$389 billion.

Investment focus

Biotechnology, Health Care, Software
Series B, Series C, Series D
United States, China, India

Portfolio highlights

UpGrad — UpGrad is an online platform that offers educational services to its clients.UpGrad’s range of programs consists of digital marketing, product management, entrepreneurship, data analytics, data-driven management, and digital technology management. It offers industry insights and student support services.UpGrad was launched in 2015 by PhalgunKompalli, Ronnie Screwvala, Ravijot Chugh, and Mayank Kumar and is based in Mumbai.
Aira — Aira operates as a clean energy-tech company.
Huize — Huize is a solid-state lithium-ion battery manufacturer and developer company.Huize is focused on the future of energy transformation, developing and manufacturing the next generation of solid-state lithium-ion batteries as well as providing system solutions.

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Investment focus

Information Technology, Biotechnology, Health Care
Series A, Series B, Seed
South Korea, Singapore, India

Portfolio highlights

Trustay — Trustay is a real estate asset management company.
AIZEN Global — AIZEN is redesigning Digital Banking with CreditConnect, powered by our proprietary ABACUS AutoML platform specialized in the financial services industry. CreditConnect is an AI lending platform designed to bridge the gap between banks and data economy platforms, and automate key decision-making processes in accordance with the credit cycle. Thecompany has secured Series B round funding from a state-led fintech innovation fund (K-Growth) led by major Korean banks to roll out CreditConnect in Southeast Asia.We are also leading the digital transformation in the financial services industry using proprietary AutoML platform ABACUS, with successful use cases in underwriting, fraud detection, product development, claim analysis, and more.
Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Investment focus

Financial Services, FinTech, Software
Series A, Seed, Funding Round
Singapore, United States, Indonesia

Portfolio highlights

WIZ.AI — WIZ.AI Talkbot is a leading Generative AI-powered omnichannel customer engagement solution for enterprises to propel business growth.
Abound — Fintern is a lending startup looking to offer an AI-driven alternative to costly payday loans. It aims to expand access to low-cost personal credit by using the UK’s new Open Banking standard to analyze consumers’ historical bank statement data. Open Banking data allows us to build a granular view of customers’ financial circumstances, properlyunderstand their affordability, and place less reliance on credit reference agency scores.The company was founded in 2020 and is based in London, United Kingdom.
Sending Network — A super-app that combines chat, socializing, and trade, giving you complete control over your social data, while you build communities and share ideas, seamlessly.

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Ireland, Singapore

Portfolio highlights

Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.

Catalysing smart monies into Singapore-based, early-stage technology startups.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Funding Round
Singapore, United States, Hong Kong

Portfolio highlights

DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
Aevice Health — Meet our AeviceMD, all-in-one sensor to deliver hospital-quality insights, right from home.
Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Investment focus

Apps, E-Commerce, Information Technology
Series A, Series B, Seed
South Korea, United States, Singapore

Portfolio highlights

Rovigos — Rovigos analyzes data from your whole business to help you make better forecasts and choices.
Easy Charger — Easy Charger provides EV infrastructure, electric two-wheeled vehicle battery station, solar power, and platform development services.
Travel Wallet — Travel Wallet is a foreign currency payment service that uses the Travel Wallet application. The travel Pay card is free of charge for overseas payments. The payments are overseas direct purchases and overseas payments without commission. The license for small overseas remittance businesses and electronic financial businesses by meeting variouscomputer facilities and all requirements. The platform agreement with banks.

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Investment focus

Biotechnology, Health Care, Software
Series A, Series B, Funding Round
South Korea, United States, Japan

Portfolio highlights

Xpanner — Xpanner(Builtworlds Top 50), digital contech site solution, not only can bring productivity improvement(by 15% average), management efficency, safety and ESG improvement through our smart integration of conTech disparate products.
Storelink — Storelink is an open market optimization platform that analyzes and processes accurate online sales data.
AIGEN Sciences — We aim to advance current state-of-the-art AI drug discovery technologies and transform high-cost, low-efficiency drug discovery practices into rapid, efficient discovery, ultimately leading to high success rates in the clinical phase. Our award-winning AI drug discovery platform enables the direct

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Investment focus

Financial Services, Software, SaaS
Series A, Series B, Seed
South Korea, India, Vietnam

Portfolio highlights

Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
BlockOdyssey — BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'.Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, andis conducting business with French pharmaceutical companies.

Altara Ventures aims to invest in the fintech, consumer, enterprise software, logistics, healthcare and edutech verticals.

Investment focus

Health Care, Software, Information Technology
Series A, Seed, Series B
Indonesia, Singapore, India

Portfolio highlights

Buyandship — Buyandship provides cross-border eCommerce solution focusing on Marketing and Logistics. At Buyandship, is redefining the experience of E-Commerce without changing the sites, disrupting the underlying infrastructure, we provide consolidate, aggregate and load-balance shipments across the world to the consumer's doorstep. Our technologyfocuses on connecting the fragmented existing logistics infrastructure to create a seamless experience for both merchants and consumers, and the benefit is that they get a solution that is 30-50% less than other carriers. We also work with merchants, marketplaces, and platforms to create a channel to reach an audience across our geographies (9 Countries currently) and reaching over 1.5M+ people per month whilst growing. We envision our members being able to purchase from any site around the world and have it seamlessly be shipped home. No more geographical restrictions, No more price monopolies, No more ambiguous shipping situations. We are building towards a transparent system, where both buyers and sellers just focus on the product.
Kita Agritech — Kita's objective is to jointly and sustainably improve the livelihoods of Filipino farmers through the application of contemporary supply chain technology and AI.
Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Canada, United Kingdom

Portfolio highlights

Inversago Pharma — Inversago Pharma is a preclinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.

Investors by industry